Rational Design of Effective Therapeutics for Treatment of the 1282X CFTR Disorder
Awardee: Cooperman
Institution: University of Pennsylvania
Award Amount: $53,000
Funding Period: January 1, 2017 - December 31, 2017
Previous
Previous
Gene-edited stem cells for modeling rare mutations in cystic fibrosis (CF)
Next
Next